Inhibition of monoamine oxidases by functionalized coumarin derivatives: Biological activities, QSARs, and 3D-QSARs

Journal of Medicinal Chemistry

Volumn 43, Issue 25, 2000, Pages 4747-4758

  Gnerre, C ^a   Catto, M ^b   Leonetti, F ^b   Weber, P ^a   Carrupt, P A ^a   Altomare, C ^b   Carotti, A ^b   Testa, B ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

7 [(3,4 DIFLUOROBENZYL)OXY] 3,4 DIMETHYLCOUMARIN; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; COUMARIN DERIVATIVE; FUNCTIONAL GROUP; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ELECTRIC ACTIVITY; ENZYME INHIBITION; LIPOPHILICITY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL ANALYSIS; THREE DIMENSIONAL IMAGING;

ANIMALS; BICYCLO COMPOUNDS; CHROMONES; COUMARINS; MODELS, MOLECULAR; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0034649564     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm001028o     Document Type: Article

References (57)

1. cDNA cloning of human liver monoamine oxidase A and B: Molecular basis of differences in enzymatic properties
2. Tissue distribution of human monoamine oxidase A and B mRNA
3. L-Dopa in the treatment of Parkinson's disease: A consensus meeting
4. New drugs for the treatment of Parkinson's disease
5. Drug treatment of Parkinson's disease
6. Induction of apoptosis in catecholaminergic PC12 cells by L-dopa. Implications for the treatment of Parkinson's disease
7. Protection against aptotosis by monoamine oxidase A inhibitors
8. Selective inhibitors of monoamine oxidase. 3. Structure-activity relationship of tricyclic bearing imidazoline, oxadiazole, or tetrazole groups
9. Neuropathology of Parkinson's disease
10. Structural aspects of monoamine oxidase and its reversible inhibition
11. Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism
12. Molecular determinants in the bioactivation of the dopaminergic neurotoxin N-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP)
13. Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine
14. Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potential
15. A new series of coumarin derivatives having monoamine oxidase inhibitory activity from Monascus anka
16. Synthesis of coumarins as subtype-selective inhibitors of monoamine oxidase
17. Uber die verbindungen der Phenole mit Acetessigather
18. The Pechmann reaction
19. Darstellung stilbenartiger Verbindungen nach der Methode von G
20. Light-induced and related reactions of quinones. Part VIII. Some (2-hydroxyalkyl)-, phenethyl-, (2-ethoxycarbonylethyl)-, and styryl-1,4-benzoquinones
21. Synthesis of 7-hydrocoumarins catalysed by solid acid catalysts
22. Studies on the 4-hydroxycoumarins. Synthesis, of the metabolites and some other derivatives of warfarin
23. Cyclic lactones
24. The antioxygenic property of hydroxycoumarins
25. Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones
26. Molecular rearrangement of some o-acyloxyacylactones in the presence of metallic sodium
27. Synthetic analgesics. XVI. Synthesis of 1-(2tertiary aminoalkyl)-3,4-dihydrocarbostyryls
28. Effects of [(N-alkyl-1,3-dioxo-1H,3H-isoindolin-5-yl)oxy]alkanoic acids, [(N-alkyl-1-oxo-1H,3H-isoindolin-5-yl)oxy]butanoic acids, and related derivatives on chloride influx in primary astrogial cultures
29. A simple preparation of phenols from diazonium ions via the generation and oxidation of aryl radicals by copper salts
30. The parametrization of lipophiIicity and other structural properties in drug design
31. Determination of positional weighting factors for the Swain and Lupton substituent constants F and R
32. Inhibition of monoamine oxidase-B by 5H-indeno[1,2-c]pyridazine derivatives: Biological activities, quantitative structure - Activity relationships (QSARs) and 3D-QSARs
33. Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: Effects of lipophilicity and structure - Activity relationships
34. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins
35. Deactivated hydrocarbonaceous silica and immobilized artificial membrane stationary phases in high-performance liquid chromatographic determination of hydrophobicities of organic bases: Relationship to log P and CLOGP
36. Comparison of classical and 3D QSAR
37. Ribonuclease T1: Structure, function, and stability
38. Substituted coumarins and azacoumarins. Synthesis and fluorescent properties
39. Unusual regioselectivity in the reduction of α,β-unsaturated carbonyl compounds with diisobutylaluminium hydride (DIBAH): Direct conversion of isoflavones to iso-flavan-4-ones
40. Synthetical experiments in the chromone group. Part XVI. Chalcones and flavanones and their oxidation to flavones by means of selenium dioxide
41. Synthetical experiments in the chromone group. Part XVII. Further observations on the action of sodamide on o-acyloxyacetophenones
42. Furanochromones. Part IV. Synthesis of 2-(methylfurano)-3',2'-(6,7)-chromone and derivatives thereof
43. The preparation of some phthalazines and related substances
44. 3,4-Methylenedioxyphenoxy compounds as synergists for natural and synthetic pyrethrins
45. 1]-3,4-dihydro-7-hydroxy- 1-hydroxyethylquinolinone
46. Inhibition of monoamine oxidase by isoquinoline derivatives: Qualitative and 3D-quantitative structure - Activity relationships
47. Substituted xanthones as selective and reversible monoamine oxidase A (MAO-A) inhibitors
48. Determination of ionization constants by spectrophotometry
49. Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions
50. Molecular lipophilicity potential, a tool in 3D-QSAR. Method and applications